• OPEN AN ACCOUNT
Indian Indices
Sensex
78,499.17 -455.59
( -0.58%)
Global Indices
Nasdaq
53,904.84 -465.28
(-0.86%)
Dow Jones
7,729.00 -15.55
(-0.20%)
Hang Seng
65,597.55 -85.71
(-0.13%)
Nikkei 225
10,873.25 -15.05
(-0.14%)
Forex
USD-INR
95.07 -0.16
(-0.17%)
EUR-INR
109.74 0.07
(0.06%)
GBP-INR
127.99 0.00
(0.00%)
JPY-INR
0.60 0.00
(-0.16%)

EQUITY - MARKET SCREENER

Vivimed Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532660
INE526G01021
-18.1148384
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VIVIMEDLAB
0
41.79
EPS(TTM)
Face Value()
Div & Yield %
0
2
0
 

havells india ltd
Aurum Proptech reports consolidated net profit of Rs 16.64 crore in the March 2026 quarter
Apr 24,2026
Net profit of Aurum Proptech reported to Rs 16.64 crore in the quarter ended March 2026 as against net loss of Rs 7.20 crore during the previous quarter ended March 2025. Sales rose 82.80% to Rs 123.85 crore in the quarter ended March 2026 as against Rs 67.75 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 1.90 crore in the year ended March 2026 as against net loss of Rs 33.36 crore during the previous year ended March 2025. Sales rose 50.77% to Rs 381.09 crore in the year ended March 2026 as against Rs 252.77 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales123.8567.75 83 381.09252.77 51
OPM %22.9620.65 -22.1215.52 -
PBDT29.7213.73 116 88.7836.70 142
PBT1.85-8.60 LP -14.96-43.40 66
NP16.64-7.20 LP 1.90-33.36 LP